Literature DB >> 11432739

Modulation of the lipid binding properties of the N-terminal domain of human apolipoprotein E3.

P M Weers1, V Narayanaswami, R O Ryan.   

Abstract

Apolipoprotein E (apoE) plays a critical role in plasma lipid homeostasis through its function as a ligand for the low-density lipoprotein (LDL) receptor family. Receptor recognition is mediated by residues 130-150 in the independently folded, 22-kDa N-terminal (NT) domain. This elongated globular four-helix bundle undergoes a conformational change upon interaction with an appropriate lipid surface. Unlike other apolipoproteins, apoE3 NT failed to fully protect human LDL from aggregation induced by treatment with phospholipase C. Likewise, in dimyristoylglycerophosphocholine (Myr2Gro-PCho) vesicle transformation assays, 100 microg apoE3 NT induced only 15% reduction in vesicle (250 microg) light scattering intensity after 30 min. ApoE3 NT interaction with modified lipoprotein particles or Myr2Gro-PCho vesicles was concentration-dependent whereas the vesicle transformation reaction was unaffected by buffer ionic strength. In studies with the anionic phospholipid dimyristoylglycerophosphoglycerol, apoE3 NT-mediated vesicle transformation rates were enhanced > 10-fold compared with Myr2Gro-PCho and activity decreased with increasing buffer ionic strength. Solution pH had a dramatic effect on the kinetics of apoE3 NT-mediated Myr2Gro-PCho vesicle transformation with increased rates observed as a function of decreasing pH. Fluorescence studies with a single tryptophan containing apoE3 NT mutant (L155W) revealed increased solvent exposure of the protein interior at pH values below 4.0. Similarly, fluorescent dye binding experiments with 8-anilino-1-naphthalene sulfonate revealed increased exposure of apoE3 NT hydrophobic interior as a function of decreasing pH. These studies indicate that apoE3 NT lipid binding activity is modulated by lipid surface properties and protein tertiary structure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432739     DOI: 10.1046/j.1432-1327.2001.02282.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  17 in total

1.  Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties.

Authors:  Angeliki Chroni; Serapion Pyrpassopoulos; Angelos Thanassoulas; George Nounesis; Vassilis I Zannis; Efstratios Stratikos
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

2.  Apolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants.

Authors:  Kasuen Wong-Mauldin; Vincent Raussens; Trudy M Forte; Robert O Ryan
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

3.  Apolipoprotein-induced conversion of phosphatidylcholine bilayer vesicles into nanodisks.

Authors:  Chung-Ping Leon Wan; Michael H Chiu; Xinping Wu; Sean K Lee; Elmar J Prenner; Paul M M Weers
Journal:  Biochim Biophys Acta       Date:  2010-11-25

4.  A two-step binding model of PCSK9 interaction with the low density lipoprotein receptor.

Authors:  Taichi Yamamoto; Christine Lu; Robert O Ryan
Journal:  J Biol Chem       Date:  2010-12-11       Impact factor: 5.157

Review 5.  The helix bundle: a reversible lipid binding motif.

Authors:  Vasanthy Narayanaswami; Robert S Kiss; Paul M M Weers
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2009-09-19       Impact factor: 2.320

6.  Semisynthesis and segmental isotope labeling of the apoE3 N-terminal domain using expressed protein ligation.

Authors:  Paul S Hauser; Vincent Raussens; Taichi Yamamoto; Gezman E Abdullahi; Paul M M Weers; Brian D Sykes; Robert O Ryan
Journal:  J Lipid Res       Date:  2008-12-19       Impact factor: 5.922

7.  Apolipoprotein E isoform-specific binding to the low-density lipoprotein receptor.

Authors:  Taichi Yamamoto; Hyung Won Choi; Robert O Ryan
Journal:  Anal Biochem       Date:  2007-09-11       Impact factor: 3.365

8.  Apolipoprotein E and cholesterol in aging and disease in the brain.

Authors:  Elena Posse de Chaves; Vasanthy Narayanaswami
Journal:  Future Lipidol       Date:  2008-10

9.  Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E.

Authors:  Shiori Tamamizu-Kato; Jason Yiu Wong; Vikram Jairam; Koji Uchida; Vincent Raussens; Hiroyuki Kato; Jean-Marie Ruysschaert; Vasanthy Narayanaswami
Journal:  Biochemistry       Date:  2007-06-20       Impact factor: 3.162

10.  The N-terminus of apolipoprotein A-V adopts a helix bundle molecular architecture.

Authors:  Kasuen Wong; Jennifer A Beckstead; Dustin Lee; Paul M M Weers; Emmanuel Guigard; Cyril M Kay; Robert O Ryan
Journal:  Biochemistry       Date:  2008-07-25       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.